Authors: Audet, MC Moreau, M Koltun, WD Waldbaum, AS Shangold, G Fisher, AC Creasy, GW

Citation: Mc. Audet et al., Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive - A randomized controlled trial, J AM MED A, 285(18), 2001, pp. 2347-2354

Authors: Abrams, LS Skee, DM Natarajan, J Wong, FA Leese, PT Creasy, GW Shangold, MM

Citation: Ls. Abrams et al., Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra (TM)/Evra (TM)) under conditions of heat, humidity, and exercise, J CLIN PHAR, 41(12), 2001, pp. 1301-1309

Authors: Hampton, RM Short, M Bieber, E Bouchard, C Ayotte, N Shangold, G Fisher, AC Creasy, GW

Citation: Rm. Hampton et al., Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20, CONTRACEPT, 63(6), 2001, pp. 289-295

Authors: Romero, R Sibai, BM Sanchez-Ramos, L Valenzuela, GJ Veille, JC Tabor, B Perry, KG Varner, M Goodwin, TM Lane, R Smith, J Shangold, G Creasy, GW

Citation: R. Romero et al., An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue, AM J OBST G, 182(5), 2000, pp. 1173-1183

Authors: Valenzuela, GJ Sanchez-Ramos, L Romero, R Silver, HM Koltun, WD Millar, L Hobbins, J Rayburn, W Shangold, G Wang, J Smith, J Creasy, GW

Citation: Gj. Valenzuela et al., Maintenance treatment of preterm labor with the oxytocin antagonist atosiban, AM J OBST G, 182(5), 2000, pp. 1184-1190